Medical device recalls: July 2020
The FDA posted 74 medical device recall records in July 2020, from 15 recall events by 14 companies. 38 are Class I, the most serious category.
Each product in a recall gets its own record, so one recall event can cover several records. What recall classes mean.
Companies with the most recall events
- Shanghai United Imaging Healthcare Co., Ltd. · 2 events, 4 records
- CME America, LLC · 1 event, 37 records, 37 Class I
- Becton Dickinson & Company · 1 event, 12 records
- Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) · 1 event, 9 records
- DiaSorin Molecular LLC · 1 event, 3 records
- Djo, LLC · 1 event, 1 record
- Edwards Lifesciences, LLC · 1 event, 1 record
- Mako Surgical Corporation · 1 event, 1 record
FDA root cause
- Device Design · 41
- Process control · 14
- Software design · 11
- Under Investigation by firm · 5
- Software Design Change · 1
- Process design · 1
- Process change control · 1
Class I recalls (38)
The most serious: a reasonable probability that using the device will cause serious health problems or death.
- Z-2553-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2554-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2555-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2556-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2557-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2558-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2559-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2560-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2561-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2562-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2563-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2564-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2565-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2566-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2567-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2568-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2569-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2570-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2571-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2572-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2573-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2574-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2575-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2576-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2577-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2578-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2579-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2580-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2581-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2582-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2583-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2584-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2585-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2586-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2587-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2588-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2589-2020 · CME America, LLC · posted Jul 15, 2020 · Terminated
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
- Z-2476-2020 · Verathon, Inc. · posted Jul 10, 2020 · Terminated
When video laryngoscopy system users apply, twisting motions while connecting the blade in the HDMI port, or excessive torsion to the connection port, this force is transferred to the HDMI PCB, which may result in video synchronization interruption, loss…
Class II recalls (36)
The device may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
- Z-2745-2020 · Mako Surgical Corporation · posted Jul 31, 2020 · Terminated
Characterization issue associated with the product. This issue may cause a discrepancy during bone preparation in certain Mako Total Hip procedures.
- Computed Tomography X-ray SystemClass IIZ-2703-2020 · Shanghai United Imaging Healthcare Co., Ltd. · posted Jul 27, 2020 · Open, Classified
The metal edge overlap of the mylar strip in the gantry was uneven, which may create a sharp edge.
- Computed Tomography X-ray SystemClass IIZ-2704-2020 · Shanghai United Imaging Healthcare Co., Ltd. · posted Jul 27, 2020 · Open, Classified
The metal edge overlap of the mylar strip in the gantry was uneven, which may create a sharp edge.
- Computed Tomography X-ray SystemClass IIZ-2705-2020 · Shanghai United Imaging Healthcare Co., Ltd. · posted Jul 27, 2020 · Open, Classified
The metal edge overlap of the mylar strip in the gantry was uneven, which may create a sharp edge.
- Z-2706-2020 · Richard Wolf GmbH · posted Jul 27, 2020 · Terminated
Tube material of a smaller diameter was used.
- Z-2702-2020 · Smith & Nephew, Inc. · posted Jul 24, 2020 · Open, Classified
The T-Fix sterile package contains only one sleeve instead of two, The device will not perform as intended for the second bone tunnel due to the absence of thesleeve
- Z-2641-2020 · Shanghai United Imaging Healthcare Co., Ltd. · posted Jul 20, 2020 · Open, Classified
Two issues were identified with the computed tomography x-ray system including a service function which may cause false marking of a bad channel resulting in ring artifacts, and potential intermittent scout scanning interruption due to occasional angle…
- Z-2660-2020 · Becton Dickinson & Company · posted Jul 20, 2020 · Terminated
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A…
- Z-2661-2020 · Becton Dickinson & Company · posted Jul 20, 2020 · Terminated
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A…
- Z-2662-2020 · Becton Dickinson & Company · posted Jul 20, 2020 · Terminated
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A…
- Z-2663-2020 · Becton Dickinson & Company · posted Jul 20, 2020 · Terminated
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A…
- Z-2664-2020 · Becton Dickinson & Company · posted Jul 20, 2020 · Terminated
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A…
- Z-2665-2020 · Becton Dickinson & Company · posted Jul 20, 2020 · Terminated
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A…
- Z-2666-2020 · Becton Dickinson & Company · posted Jul 20, 2020 · Terminated
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A…
- Z-2667-2020 · Becton Dickinson & Company · posted Jul 20, 2020 · Terminated
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A…
- Z-2668-2020 · Becton Dickinson & Company · posted Jul 20, 2020 · Terminated
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A…
- Z-2669-2020 · Becton Dickinson & Company · posted Jul 20, 2020 · Terminated
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A…
- Z-2670-2020 · Becton Dickinson & Company · posted Jul 20, 2020 · Terminated
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A…
- SafeStep Huber Needle SetClass IIZ-2671-2020 · Becton Dickinson & Company · posted Jul 20, 2020 · Terminated
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A…
- Z-2590-2020 · Djo, LLC · posted Jul 13, 2020 · Terminated
The device accessories were not labeled with appropriate latex warning.
- Sterile Oxymetry Oligon Catheter Kit. Pressure injectable. REF/UDI:XA3816SAFKT/ (01)00690103197181 ↗Class IIZ-2007-2020 · Edwards Lifesciences, LLC · posted Jul 10, 2020 · Terminated
Sterile catheter kit packaging compromised.
- Z-2505-2020 · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) · posted Jul 10, 2020 · Open, Classified
There is a rare communication sequence during the first device interrogation with a SmartSync Device Manager that may result in the temporary suspension of some device features (i.e., battery measurements, Capture Management", Atrial Lead Position Check",…
- Z-2506-2020 · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) · posted Jul 10, 2020 · Open, Classified
There is a rare communication sequence during the first device interrogation with a SmartSync Device Manager that may result in the temporary suspension of some device features (i.e., battery measurements, Capture Management", Atrial Lead Position Check",…
- Z-2507-2020 · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) · posted Jul 10, 2020 · Open, Classified
There is a rare communication sequence during the first device interrogation with a SmartSync Device Manager that may result in the temporary suspension of some device features (i.e., battery measurements, Capture Management", Atrial Lead Position Check",…
- Z-2508-2020 · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) · posted Jul 10, 2020 · Open, Classified
There is a rare communication sequence during the first device interrogation with a SmartSync Device Manager that may result in the temporary suspension of some device features (i.e., battery measurements, Capture Management", Atrial Lead Position Check",…
- Z-2509-2020 · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) · posted Jul 10, 2020 · Open, Classified
There is a rare communication sequence during the first device interrogation with a SmartSync Device Manager that may result in the temporary suspension of some device features (i.e., battery measurements, Capture Management", Atrial Lead Position Check",…
- Z-2510-2020 · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) · posted Jul 10, 2020 · Open, Classified
There is a rare communication sequence during the first device interrogation with a SmartSync Device Manager that may result in the temporary suspension of some device features (i.e., battery measurements, Capture Management", Atrial Lead Position Check",…
- Z-2511-2020 · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) · posted Jul 10, 2020 · Open, Classified
There is a rare communication sequence during the first device interrogation with a SmartSync Device Manager that may result in the temporary suspension of some device features (i.e., battery measurements, Capture Management", Atrial Lead Position Check",…
- Z-2512-2020 · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) · posted Jul 10, 2020 · Open, Classified
There is a rare communication sequence during the first device interrogation with a SmartSync Device Manager that may result in the temporary suspension of some device features (i.e., battery measurements, Capture Management", Atrial Lead Position Check",…
- Z-2513-2020 · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) · posted Jul 10, 2020 · Open, Classified
There is a rare communication sequence during the first device interrogation with a SmartSync Device Manager that may result in the temporary suspension of some device features (i.e., battery measurements, Capture Management", Atrial Lead Position Check",…
- Z-2523-2020 · Philips North America, LLC · posted Jul 10, 2020 · Terminated
Thermo switches in the main power supply for the system may be incorrectly installed, resulting in a malfunction.
- Z-2537-2020 · Vitalconnect Inc. · posted Jul 10, 2020 · Terminated
A healthcare provider (HCP) noticed a patient had a lowered historic SpO2 reading that the software should have triggered a notification to the care team, but no notification was found. A software defect was encountered causing the lack of notification.…
- MOL2150 Simplexa HSV 1&2 DirectClass IIZ-2547-2020 · DiaSorin Molecular LLC · posted Jul 10, 2020 · Terminated
Due to a software malfunction in the Multi Assay Suite, there is the probability of increased occurrence of false negative results.
- Z-2548-2020 · DiaSorin Molecular LLC · posted Jul 10, 2020 · Terminated
Due to a software malfunction in the Multi Assay Suite, there is the probability of increased occurrence of false negative results.
- Z-2549-2020 · DiaSorin Molecular LLC · posted Jul 10, 2020 · Terminated
Due to a software malfunction in the Multi Assay Suite, there is the probability of increased occurrence of false negative results.
- Z-2497-2020 · Ra Medical Systems, Inc. · posted Jul 4, 2020 · Terminated
A software issue was identified which could result in user or patient injury, or may adversely impact laser performance. It is possible that an unintended release of laser light (radiation) may occur, injuring the user or patient.
Source: FDA Medical Device Recalls and FDA enforcement reports (recall class), via openFDA. Records are grouped by the date the FDA posted them. Methodology · Not medical advice.